Mesenchymal stem cells (MSCs) have been reported to exert therapeutic effects on
immunoregulation, tissue repair, and regeneration from the bench to the bedside. Increasing …

As a cause of postoperative complications and early hepatic failure after liver
transplantation, liver ischemia/reperfusion injury (IRI) still has no effective treatment during …

As nanotherapeutics, mesenchymal stromal cell-derived extracellular vesicles (MSC-EVs)
are considered a potent alternative for whole-cell therapy and are gradually entering the …

Hepatic ischemia/reperfusion injury (IRI) and associated inflammation contributes to liver
dysfunction and complications after liver surgery and transplantation. Mesenchymal stem …

Hepatic ischemia reperfusion injury (IRI) remains a major obstacle in liver resection and
transplantation surgery, especially in diseased organs. Human mesenchymal stromal cells …

Mesenchymal stem cells (MSCs) have been increasingly applied into clinical therapy.
Exosomes are small (30–100 nm in diameter) membrane vesicles released by different cell …

The purpose of this study was to explore the mechanism by which human umbilical cord
blood mesenchymal stem cells (hUCB‐MSCs)‐derived exosomes exerted protective effect …

The purpose of this study was to explore the associated mechanism by which MSCs-derived
exosomes exerted protective effect in hepatic ischemia/reperfusion injury (IRI). Human …

Mesenchymal stem cells (MSCs) have been proved to exert considerable therapeutic effects
on ischemia‐reperfusion (I/R)‐induced injury, but the underlying mechanism remains …

Stem cell-based therapies have potential for treatment of liver injury by contributing to
regenerative responses, through functional tissue replacement or paracrine effects. The …